Physician profile
Amy E Schleifer
NPI 1194784363
$3,817.97
in general payments reported to CMS, 2019-2025
21 companies · $996 in 2025
The $996 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $526 · 2022: $808 · 2023: $651 · 2024: $837 · 2025: $996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,483.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $887.89 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $579.86 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $507.77 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $405.33 | 2021-2025 | |
| Lilly USA, LLC | $203.69 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $192.27 | 2022-2025 | Proclaim, Freestyle Libre 3, Freestyle Libre 2 |
| Abiomed | $136.99 | 2023-2024 | Impella |
| Janssen Pharmaceuticals, INC | $118.62 | 2021-2022 | |
| Astellas Pharma US INC | $110.42 | 2021-2023 | Veozah, Myrbetriq |
| Dexcom, INC. | $104.19 | 2021-2022 | |
| Amgen INC. | $77.73 | 2023-2024 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $73.36 | 2021-2025 | Trelegy Ellipta, Shingrix |
| Boston Scientific Corporation | $72.47 | 2022-2024 | Watchman Access System, Watchman Flx |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.51 | 2021-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.99 | 2021-2025 | Stiolto Respimat, Jardiance |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $50.67 | 2022 | |
| Amarin Pharma, INC. | $48.86 | 2021-2022 | |
| Exact Sciences Corporation | $48.57 | 2025 | The Cologuard Plus Collection Kit |
| Pfizer INC. | $31.69 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $20.46 | 2023 | Eliquis |
| Sunovion Pharmaceuticals INC. | $16.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Schleifer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.